Brain Metastases in EGFR-mutant NSCLC: Outcome of Osimertinib plus /- Radiation Therapy in a Real-World Canadian Cohort

被引：0
|
作者：
Litt, I. [1 ]
Gibson, A. [2 ]
Dean, M. [2 ]
Elegbede, A. [2 ]
Bebb, G. [2 ]
Cheung, W. [1 ]
Pabani, A. [1 ]
机构：
[1] Alberta Hlth Serv, Calgary, AB, Canada
[2] Univ Calgary, Calgary, AB, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Non-small cell lung cancer; Targeted Therapies; Brain Metastases;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.02-07
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [1] Post-Progression Analysis of EGFR-Mutant NSCLC Following Osimertinib Therapy in Real-World Settings
    Attili, Ilaria
    Corvaja, Carla
    Spitaleri, Gianluca
    Aliaga, Pamela Trillo
    Del Signore, Ester
    Passaro, Antonio
    de Marinis, Filippo
    CANCERS, 2024, 16 (14)
  • [2] Safety of osimertinib plus chemotherapy in EGFR-mutant NSCLC
    Piotrowska, Zofia
    Liu, Stephen V.
    Muzikansky, Alona
    Marcoux, Nicolas
    Banwait, Mandeep
    Stevens, Sara
    Goodwin, Kelly
    Lafferty, Tracey E.
    Ackil, Jennifer
    Krueger, Elizabeth A.
    Heist, Rebecca Suk
    Lin, Jessica Jiyeong
    Gainor, Justin F.
    Hata, Aaron N.
    Shaw, Alice Tsang
    Sequist, Lecia V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC
    Wang, Kaiwen
    Du, Robyn
    Myall, Nathaniel J.
    Lewis, Whitney E.
    Uy, Natalie
    Hong, Lingzhi
    Skoulidis, Ferdinandos
    Byers, Lauren A.
    Tsao, Anne
    Cascone, Tina
    Pozadzides, Jenny
    Tu, Janet
    Negrao, Marcelo, V
    Gibbons, Don L.
    Park, Keunchil
    Rinsurongkawong, Waree
    Lee, J. Jack
    Gandara, David
    Behl, Deepti
    Shu, Catherine A.
    Riess, Jonathan W.
    Baik, Christina
    Wakelee, Heather A.
    Vaporciyan, Ara A.
    Heymach, John, V
    Zhang, Jianjun
    Le, Xiuning
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (03) : 500 - 506
  • [4] Osimertinib versus First-Generation EGFR-TKIs in Untreated EGFR-Mutant NSCLC with Brain Metastasis: 362 Real-World Cases
    Zhao, Y.
    Li, S.
    Zhu, Z.
    Ni, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S624 - S625
  • [5] A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
    Morimoto, Kenji
    Sawada, Ryo
    Yamada, Tadaaki
    Azuma, Koichi
    Ito, Kentaro
    Goto, Yasuhiro
    Kimura, Hideharu
    Harada, Taishi
    Shiotsu, Shinsuke
    Tamiya, Nobuyo
    Chihara, Yusuke
    Takeda, Takayuki
    Hiranuma, Osamu
    Hasegawa, Isao
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (09):
  • [6] Real-world Experience of the Utility in Afatinib Therapy for Patients with EGFR-Mutant Advanced NSCLC
    Igawa, S.
    Ono, T.
    Kasajima, M.
    Yamada, K.
    Oguri, A.
    Kameda, A.
    Yamamoto, H.
    Kakegawa, M.
    Hiyoshi, Y.
    Kusuhara, S.
    Ozawa, T.
    Otani, S.
    Fukui, T.
    Mitsufuji, H.
    Masaru, K.
    Yokoba, M.
    Kubota, M.
    Sasaki, J.
    Naoki, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S611 - S611
  • [7] Real-world data of osimertinib in the management of leptomeningeal metastases in EGFR mutant NSCLC: Light at the end of the tunnel?
    Sharma, Mansi
    Nathany, Shrinidhi
    Narayan, Satya
    Redhu, Pallavi
    Jain, Parveen
    Batra, Ullas
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] A brave NEO world: Neoadjuvant osimertinib in resectable EGFR-mutant NSCLC
    Cortiula, F.
    Naidoo, J.
    LUNG CANCER, 2023, 181
  • [9] Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
    Ye, Qiuyue
    Xu, Yan
    Zhao, Jing
    Gao, Xiaoxing
    Chen, Minjiang
    Pan, Ruili
    Zhong, Wei
    Wang, Mengzhao
    TRANSLATIONAL ONCOLOGY, 2023, 31
  • [10] Real world cfDNA collection in EGFR-mutant NSCLC
    Marcoux, N.
    Sequist, L. V.
    Hata, A.
    Banwait, M.
    Dagogo-Jack, I.
    Nagy, R.
    Lanman, R. B.
    Muzikansky, A.
    Digumarthy, S. R.
    Piotrowska, Z.
    ANNALS OF ONCOLOGY, 2018, 29
12345